HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

Go back to HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.40 --0 (-0%)
Previous Close $0.40    52 Week High $4.35 
Open $0.40    52 Week Low $0.44 
Day High $0.40    P/E N/A 
Day Low $0.40    EPS $-0.81 
Volume 31,900